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Helminth infection is regarded as one of the neglected tropical diseases (NTDs). Although the disease is common in rural areas, information on
the pharmacology of South African medicinal plants used against this disease is limited. We investigated the efficacy of ten South African
medicinal plants against Caenorhabditis elegans. Because of the increased susceptibility of a host to microbial infections and other inflammatory
responses associated with helminth infections, the antimicrobial and cyclooxygenase (COX) inhibitory activities of the plants were also
investigated. Phenolics including flavonoids, condensed tannins and gallotannins have been linked to many pharmacological activities. Thus, the
phenolic content of the plant extracts were quantitatively evaluated. In the three bioassays, organic solvent extracts from Cyathea dregei (roots and
leaves), Felicia erigeroides (leaves and stems), Hypoxis colchicifolia (leaves) and Senna petersiana (leaves) exhibited noteworthy
pharmacological activities while Acokanthera oppositifolia (leaves) had good COX inhibitory activity. The concentration of phenolics ranged
from 56.7 to 1.7 mg GAE/g dry matter in Ocimum basilicum and Cotyledon orbiculata var. dactylopsis, respectively. Flavonoids, condensed
tannin and gallotannin content also varied greatly among the plant extracts investigated.
© 2010 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Anthelmintic; Antimicrobial; Cyclooxygenase inhibition; Phenolic content; South African medicinal plants; Tannin1. Introduction
A large number of the SouthAfrican population still depend on
traditional medicine (TM) for their health care needs due to its
affordability, accessibility and cultural importance (Light et al.,
2005).Among the variety of diseases treated by traditional healers
in TM are helminth infections. These infections are regarded as
one of the neglected tropical diseases (NTDs) due to their high
prevalence among the economically disadvantaged people in the
rural areas in different regions of the world. In most developing
countries, helminth infections are considered a major health
concern because the factors that predispose humans to these
infections abound in these regions (Ijagbone and Olagunju,
2006). Poor sanitation, poverty, unsafe water, malnutrition and⁎ Corresponding author. Tel.: +27 33 2605130; fax: +27 33 2605897.
E-mail address: rcpgd@ukzn.ac.za (J. Van Staden).
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doi:10.1016/j.sajb.2010.04.009ignorance are the factors that sustain the parasite life cycle and
favour the proliferation of the disease vectors (Brooker et al.,
2006). In South Africa, the prevalence of helminth infections has
been reported in provinces such as KwaZulu-Natal and
Mpumalanga. Helminth infections have remained relatively
high over time, and the most vulnerable groups are women and
children (Jinabhai et al., 2001).
Globally, a number of medicinal plants have been used for the
treatment of helminth infections by the local people (Waller et al.,
2001). South Africa is endowed with more than 24000 indigenous
plants, representing about 10% of all higher plants that occur
globally. Approximately 3000 plant species are used as medicines
by an estimated 200000 traditional healers in South Africa (Van
Wyket al., 1997).Although the plant kingdomhas remained poorly
explored, natural products isolated from plants have been
postulated to remain an essential part of the search for novel
medicines against human diseases (Balunas and Kinghorn, 2005).
There is a higher potential of discovery and development of morets reserved.
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medicinal plants have remained understudied for their pharmaco-
logical and phytochemical properties (Gurib-Fakim, 2006).
Although helminth infections do not always cause obvious
diseases, the host's health integrity could be compromised due to
the effect of themetabolic activities of the parasites on nutrition as
well as the toxic products of excretion (Deacon, 2006). This
probably accounts for the increased susceptibility and enhances
the progression of bacterial diseases such as tuberculosis and
other opportunistic infections among helminth hosts (Bentwich
et al., 1995; Brooker et al., 2004). In addition, microorganisms
such as bacteria (Escherichia coli, Klebsiella pneumoniae and
Staphylococcus aureus) and fungi (Candida albicans) have been
implicated in the increased infection rate in immune-compro-
mised patients worldwide (Sleigh and Timburg, 1998). Globally,
the increase in helminth infection and their growing resistance to
most chemotherapeutics is a major problem facing human health
(James and Davey, 2009). In addition, research on the discovery
of new chemotherapies for helminth infections has been neglected
by governments, researchers and the pharmaceutical industries
due to the poor economic prospects and the presumed low priority
of the diseases that go with it (Geary et al., 1999).
The importance of pharmacological screening of plant extracts
for multiple biological activities has been extensively documen-
ted (Houghton et al., 2005). The importance has been
demonstrated for diseases such as Alzheimer's and diabetes.
The use of multiple bioassays gives a clearer indication of the
effect of the extracts in relation to the disease state (Houghton
et al., 2007). This study was aimed at screening extracts of
medicinal plants to determine their efficacy as anthelmintics.
Besides the anthelmintic investigation, antimicrobial activity and
cyclooxygenase (COX) enzymes inhibition of the plant extracts
were carried out as microbial infection and pain are often
associated with helminth diseases. The plant extracts were also
investigated for phenolic composition, to provide a clue on
different phenolic compounds that could be responsible for any
biological activity observed.
2. Materials and methods
2.1. Plant collection and extract preparation
Plant material of ten species (Table 1) was collected from the
University of KwaZulu-Natal (UKZN) Botanical Garden, Pieter-
maritzburg and Mount Gilboa (29° 15.450′ S, 30° 20.289′ E)
between February andApril 2009. Voucher specimens of the plants
were deposited in the UKZN Herbarium, Pietermaritzburg. For
sustainable harvesting, twigs and leaves of Acokanthera opposi-
tifolia were substituted for the roots. Plant material was oven dried
at 50 °C, ground into powders through a 1-mm ring sieve using an
Ultra Centrifugal Mill (ZM 200, Retsch®, Germany) and stored at
room temperature in airtight containers in the dark.
Groundmaterial (1 g) was extracted independently with 10 ml
of petroleum ether (PE), dichloromethane (DCM), ethanol
(EtOH) and water in an ultrasonic sonicator (Julabo GMBH,
West Germany) with ice for 1 h. The extracts were filtered under
vacuum through Whatman No. 1 filter paper. Organic solventextracts were concentrated in vacuo using a rotary evaporator
(Büchi, Germany) at 30 °C. The concentrates were transferred to
pre-weighed glass vials and completely dried under a stream of
air. Water extracts were collected into pre-weighed glass jars and
freeze-dried. The percentage yield (Table 3) of each dried extract
in terms of the starting plant material was determined after which
it was stored in the dark at 10 °C until required for analysis.
Phenolic compounds were extracted from dry plant material as
described by Makkar (2000). Ground plant samples (1 g) were
extracted with 10 ml of 50% methanol (MeOH) by sonication in
cold water for 20 min. The extracts were then filtered in vacuo
through Whatman No.1 filter paper.
2.2. Pharmacological evaluation
2.2.1. Anthelmintic assay
An in vitro colourimetric assay used in the determination of free-
living nematode larvae viability, as described by James and Davey
(2007) with slight modifications, was used to evaluate the
minimum lethal concentration (MLC) values of the extracts. A 3-
day-old Caenorhabditis elegans var. Bristol (N2) culture was
prepared by subculturing a stock culture seeded with autoclaved E.
coli. The subcultured C. elegans was washed with 5 ml of M9
buffer (Brenner, 1974) into a sterile McCartney bottle and, using a
UV–visible spectrophotometer (Varian Cary 50, Australia), the
optical density (OD) at 530 nm was measured. Thereafter, 5 ml of
M9 buffer (sufficient for inoculating one microtitre plate) were
adjusted with appropriate volumes of the prepared stock of C.
elegans culture to obtain a culture mixture in the OD530 range of
0.04–0.06 (approximately 100 worms per 50 µl). Organic solvent
extracts were redissolved in DMSO (25 mg/ml), and water extracts
in sterile water (50 mg/ml). Each redissolved extract (100 µl) was
two-fold serially diluted with 100 µl sterile distilled water down a
96-well microtitre plate. A similar two-fold serial dilution of 100 µl
of 1 mg/ml levamisole (Sigma-Aldrich, Germany) was used as a
reference drug. The prepared C. elegans culture (50 µl) containing
approximately 100 worms (C. elegans) were added to each well of
the microtitre plate. C. elegans culture, DMSO and water were
included as controls. The microtitre plates were covered with
parafilm and incubated at 20 °C for 48 h in the dark. Thereafter,
50 µl of 1.25 mg/ml p-iodonitrotetrazolium chloride (INT)
(Sigma-Aldrich, Germany) was added to the wells of the
microtitre plate and further incubated at 20 °C for 24 h. Active
organisms biologically reduce the colourless INT to a pink–
red colour (McGaw et al., 2007). The concentration of the
lowest clear well was recorded as the MLC value of the
extract. Extracts were screened in duplicate and the assay was
repeated twice.
2.2.2. Antimicrobial assay
2.2.2.1. Antibacterial assay. Minimum inhibitory concentra-
tion (MIC) values of extracts against four representative bacterial
strains were determined using the microplate technique (Eloff,
1998a).Overnight cultures of twoGram-positive bacteria, (Bacillus
subtilis ATCC 6051, 4.8×109 CFU/ml and S. aureus ATCC
12600, 2.7×109 CFU/ml) and two Gram-negative bacteria (E. coli
Table 1
South African plants used as anthelmintics based on ethnobotanical information from the literature.
Family Plant species Ethnopharmacological uses
Voucher number a
Plant part screened
Apocynaceae Acokanthera oppositifolia (Lam.) Codd Dried leaves or roots and wood are used as anthelmintics
(Hutchings et al., 1996; Van Wyk et al., 1997).A.AREMU 1 NU
Leaves, Twigs
Asteraceae Felicia erigeriodes DC. Hot leaf infusions are administered as enemas for intestinal
parasites and abdominal pains and also as purgatives
(Hutchings et al., 1996; Pooley, 1998).
A.AREMU 3 NU
Leaves, stems
Caesalpiniaceae (Fabaceae) Senna petersianna (Bolle) Lock. Senna species are used pharmaceutically in laxative preparations.
Root and leaf infusions are used as a purgative to treat stomach-ache
and intestinal worms (Van Wyk et al., 1997).
A.AREMU 7 NU
Leaves
Crassulaceae Cotyledon orbiculata var. dactylopsis Leaves are eaten as vermifuge and applied as a hot poultice to treat boils,
earache and inflammation (Watt and Breyer-Brandwijk, 1962;
Van Wyk et al., 1997).
Tölken
A.AREMU 12 NU
Leaves, stems
Crassulaceae Cotyledon orbiculata var. orbiculata Leaves are eaten as vermifuge and applied as a hot poultice to treat boils,
earache and inflammation (Watt and Breyer-Brandwijk, 1962; Van Wyk et al., 1997).A.AREMU 5 NU
Leaves, stems
Cyatheaceae Cyathea dregei Kunze Dried roots are used as an anthelmintic (Hutchings et al., 1996).
A.AREMU 2 NU
Leaves, roots
Hypoxidaceae Hypoxis colchicifolia Bak. Used as purgatives and ascarifuges in unspecified parts of Africa
(Watt and Breyer-Brandwijk, 1962).A.AREMU 10 NU
Leaves, corms
Hypoxidaceae Hypoxis hemerocallidea Fisch. and C.A. Mey. Plant decoctions have purging effects (Watt and Breyer-Brandwijk, 1962).
A.AREMU 11 NU
Leaves, corms
Lamiaceae Ocimum basilicum (L.) Juice of leaves is used to expel worms; leaves are used for respiratory disorders,
dysentery, constipation (Okujagu et al., 2006).A.AREMU 6 NU
Leaves
Verbenaceae Clerodendrum myricoides (Hochst.) Vatke. Root and leaf infusions are taken as anthelmintics; they are also used for pains in the
chest, colds, bleedings of the gums and indigestion (Hutchings et al., 1996).A.AREMU 8 NU
Leaves, stems
a Voucher number: NU = Natal University Herbarium, Pietermaritzburg.
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13883, 2.5×109 CFU/ml) were diluted with sterile Mueller–
Hinton (MH) broth. This resulted in a final inoculum of
approximately 106 CFU/ml. Each redissolved extract (100 µl)
was two-fold serially diluted with 100 µl sterile distilled water
down the wells in a 96-well microtitre plate for each of the four
bacteria. Neomycin (100 µl; 0.4 mg/ml) (Sigma-Aldrich,
Germany) was used as a reference drug against each bacterium.
Each bacterial culture (100 µl) was then added to each well. MH
broth, DMSO andwater were included as controls. The plates were
covered with parafilm and incubated at 37 °C for 24 h. After
incubation, bacterial growth was indicated by adding 50 µl of
0.2 mg/ml INT to all the wells of the microtitre plate and further
incubated at 37 °C for 1 h. Bacterial growth in the wells was
indicated by a pink–red colour, whereas clear wells indicated
growth inhibition. MIC values were recorded as the concentrations
of the lowest clear wells of each extract. The assay was repeated
twice in duplicate per test extract.
2.2.2.2. Antifungal assay. The antifungal activity of the extracts
was evaluated against C. albicans (ATCC 10231, 5×l05 CFU/ml)
using the microplate technique (Eloff, 1998a) with modifications
(Masoko et al., 2007). Sterile saline (4 ml) was added to 400 µl ofCandida overnight culture in Yeast Malt (YM) broth. The
absorbance was measured at 530 nm and adjusted with sterile
saline to match that of a 0.5 M McFarland standard solution. This
resulted in a final inoculum of approximately 106 CFU/ml. From
this stock, a 1:1000 dilution with sterile YM broth was prepared.
Amphotericin B (100 µl; 0.25 mg/ml) (Sigma-Aldrich, Germany)
was used as a reference drug. The microtitre plates were covered
with parafilm and incubated at 37 °C for 24 h afterwhich 50 µl INT
(0.2 mg/ml) was added to each well of the microtitre plate. MIC
values were recorded as the concentrations of the lowest clear wells
after 48 h. Fungicidal activity was determined by adding YMbroth
(50 µl) to all clear wells then incubating for a further 24 h.
Minimum fungicidal concentration (MFC) values were recorded as
the concentration of the lowest clear well. The assay was repeated
twice in duplicate per test extract.
2.2.3. Cyclooxygenase (COX-1 and -2) inhibition assays
COX-1 and -2 enzyme assays were performed according to the
methods by Jäger et al. (1996) as modified by Zschocke and Van
Staden (2000) to determine the COX enzyme inhibitory activity
of the plant extracts. The controls were a solvent blank (17.5 µl
water+2.5 µl EtOH), and a background (17.5 µl water+2.5 µl
EtOH) correction reaction in which the enzymes were inactivated
Table 2
Anthelmintic activity of plant extracts expressed as minimum lethal concentration
(MLC) values (mg/ml) against Caenorhabditis elegans. Values in bold indicate
high anthelmintic activity.
Plant species Plant
part
MLC (mg/ml)
PE DCM EtOH Water
Acokanthera oppositifolia Leaves 0.52 1.04 0.52 4.17
Twigs 2.08 4.17 2.08 2.08
Clerodendrum myricoides Leaves 2.08 1.04 0.26 1.04
Stems 2.08 2.08 2.08 2.08
Cotyledon orbiculata var. dactylopsis Leaves 0.52 0.52 0.26 N16.67
Stems 4.17 4.17 4.17 N16.67
Cotyledon orbiculata var. orbiculata Leaves 0.26 1.04 0.26 N16.67
Stems 4.17 4.17 8.33 8.33
Cyathea dregei Leaves 1.04 0.52 0.52 1.04
Roots 8.33 4.17 2.08 4.17
Felicia erigeroides Leaves 1.04 0.52 4.17 16.67
Stems 4.17 2.08 4.17 N16.67
Hypoxis colchicifolia Leaves 0.52 0.13 0.26 4.17
Corms 4.17 2.08 2.08 2.08
Hypoxis hemerocallidea Leaves 1.04 1.04 2.08 2.08
Corms 2.08 4.17 2.08 1.04
Ocimum basilicum Leaves 2.08 0.26 1.04 1.04
Senna petersiana Leaves 1.04 1.04 0.52 8.33
Extracting solvent: PE = petroleum ether, DCM = dichloromethane, and EtOH =
ethanol.
MLC of levamisole was 40 µg/ml.
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(16 Ci/mol; 30 µM). Indomethacin (Sigma-Aldrich, Germany)
was used as a reference drug (5 µM for COX-1 and 200 µM for
COX-2). Organic solvent and water extracts were tested at
250 µg/ml and 2 mg/ml, respectively. COX inhibition of the
extracts was calculated by comparing the amount of radioactivity
present in the sample to that in the solvent blank using the
equation:
COXInhibitionð%Þ = 1− DPMextract−DPMbackground
DPMsolvent blank−DPMbackground
  
× 100
where, DPM is the disintegrations per min of the extract,
background and solvent blank. Results were presented as means
of two experiments (n=4) and valueswere expressed as percentage
mean±standard error.
2.3. Phenolic content evaluation
The Folin-Ciocalteu (Folin-C) assay using gallic acid as a
standard was used for the evaluation of total phenolics from the
50% MeOH extracts Makkar, (2007). Total phenolic concentra-
tions were expressed as gallic acid equivalents (GAE) per gram of
dry matter.
Gallotannin content was determined using the rhodanine
assay as described by (Makkar 2007). The gallotannin
concentrations in the extracts were expressed as GAE per
gram of dry matter.
Condensed tannin content was evaluated using the butanol-
HCl assay as described by Makkar (2007) with slight modifica-
tions by Ndhlala et al. (2007). The condensed tannin content
(percentage dry matter) was calculated as equivalent amount of
leucocyanidin (LCE) using the equation below:
Condensed tanninð%Þ = A550 × 78:26 × dilution factor of extract
%dry matter
 
× 100
where, A550=absorbance of sample at 550 nm. The formula
assumes the effective E1%, 1 cm, 550 nm of leucocyanidin to be 460.
The flavonoid content was evaluated as described by
Hagerman (2002), with modifications. In triplicate, 50 µl of
each 50% MeOH extract were diluted with 950 µl of glacial
acetic acid, followed by the addition of 2.5 ml of 4% HCl in
methanol (v/v) and 2.5 ml vanillin reagent (4% vanillin in
glacial acetic acid, w/v), after which the reaction mixture was
incubated for 20 min at room temperature. The presence of
flavonoids was indicated by a pink colouration. After the
incubation period, absorbance at 500 nm was measured using a
UV–visible spectrophotometer against a blank consisting of
water instead of extract. Flavonoid content was expressed as
catechin equivalents (CTE) per gram of dry matter.
3. Results
3.1. Anthelmintic activity
The MLC values of the plant extracts against C. elegans are
presented in Table 2. In this study, we defined MLC values lessthan 1 mg/ml, between 1 and 4 mg/ml and above 4 mg/ml as
high, moderate and low anthelmintic activity, respectively. A
total of 16 organic solvent extracts exhibited high anthelmintic
activity and the DCM extract of H. colchicifolia leaves had the
most noteworthy MLC value (0.13 mg/ml). Besides the eight
water extracts that exhibited moderate anthelmintic activity,
other water extracts showed low or poor anthelmintic activity.
Of the four extracting solvents, EtOH extracts yielded the
highest number of plant extracts with high anthelmintic activity.3.2. Antimicrobial activity
The MIC values of plant extracts against the test bacteria as
well as theMIC andMFCvalues againstC. albicans are presented
in Table 3. Plant extracts with MIC or MFC values less than
1.0 mg/ml were considered as having good antimicrobial activity
(Aligiannis et al., 2001). The most noteworthy MIC values of
0.39 mg/ml were displayed by the EtOH and PE extracts of C.
dregei roots against S.aureua and B. subtilis, and S. petersiana
leaves against three bacterial strains (B. subtilis, S. aureus and K.
pneumoniae). Gram-positive bacteria were more susceptible than
the Gram-negative ones and S. aureus was the most sensitive
bacterium to the plant extracts. Although the antifungal activity of
the extracts investigatedwas generally poor, the leaf extracts ofH.
colchicifolia (PE) and O. basilicum (water) exhibited noteworthy
antifungal activity against C. albicans. Generally, the organic
solvent extracts showed better antimicrobial activity than water
extracts.
Table 3
Antimicrobial activity (MIC) of plant extracts determined using the microtitre plate dilution technique method. Values in bold (MICb1 mg/ml) are considered
noteworthy antimicrobial activity. Dry weight yield (%) from plant parts of investigated species.
Plant species Plant part Extract a Extract yield
(%)
Antibacterial activity MIC b (mg/ml) Antifungal activity
Bacteria c Candida albicans
B.s. S.a. E.c. K.p. MIC b (mg/ml) MFCd (mg/ml)
Acokanthera oppositifolia Leaves PE 3.6 3.13 3.13 3.13 3.13 6.25 6.25
DCM 5.4 3.13 3.13 3.13 1.56 3.13 6.25
EtOH 11.8 6.25 3.13 3.13 1.56 6.25 6.25
Water 22.7 12.50 6.25 6.25 6.25 12.50 N12.50
Twigs PE 5.9 6.25 6.25 3.13 3.13 6.25 6.25
DCM 7.0 3.13 3.13 3.13 3.13 6.25 6.25
EtOH 10.0 6.25 6.25 6.25 3.13 6.25 6.26
Water 20.3 12.50 6.25 6.25 6.25 12.50 12.50
Clerodendrum myricoides Leaves PE 3.2 3.13 6.25 3.13 3.13 3.13 3.13
DCM 3.5 1.56 3.13 3.13 0.78 3.13 3.13
EtOH 4.4 1.56 1.56 3.13 0.78 3.13 6.25
Water 30.3 N12.50 12.50 6.25 N12.50 N12.50 N12.50
Stems PE 0.4 3.13 1.56 3.13 3.13 3.13 3.13
DCM 0.6 6.25 6.25 6.25 3.13 3.13 3.13
EtOH 3.6 0.78 1.56 3.13 3.13 3.13 3.13
Water 13.8 N12.50 1.56 6.25 N12.50 12.50 N12.50
Cotyledon orbiculata
var. dactylopsis
Leaves PE 2.6 3.13 3.13 3.13 3.13 6.25 6.25
DCM 3.3 3.13 1.56 3.13 3.13 6.25 6.25
EtOH 1.8 1.56 1.56 1.56 3.13 6.25 6.25
Water 30.8 N12.50 N12.50 N12.50 N12.50 N12.50 N12.50
Stems PE 0.6 6.25 3.13 3.13 3.13 6.25 6.25
DCM 1.0 6.25 3.13 3.13 3.13 3.13 6.25
EtOH 0.8 6.25 3.13 3.13 3.13 6.25 6.25
Water 17.5 N12.50 N12.50 N12.50 N12.50 N12.50 N12.50
Cotyledon orbiculata
var. orbiculata
Leaves PE 1.7 3.13 3.13 3.13 3.13 6.25 6.25
DCM 2.1 3.13 1.56 3.13 3.13 6.25 6.25
EtOH 1.5 1.56 1.56 1.56 3.13 6.25 6.25
Water 33.8 N12.50 N12.50 N12.50 N12.50 N12.50 N12.50
Stems PE 0.5 6.25 3.13 3.13 3.13 6.25 6.25
DCM 0.7 6.25 3.13 3.13 3.13 3.13 6.25
EtOH 3.0 6.25 3.13 3.13 3.13 6.25 6.25
Water 15.6 N12.50 N12.50 N12.50 N12.50 N12.50 N12.50
Cyathea dregei Leaves PE 4.0 6.25 3.13 6.25 6.25 6.25 6.25
DCM 4.4 3.13 3.13 3.13 3.13 3.13 6.25
EtOH 6.4 3.13 3.13 3.13 3.13 6.25 6.25
Water 6.8 12.50 3.13 3.13 6.25 6.25 N12.50
Roots PE 0.2 0.39 0.78 3.13 3.13 3.13 6.25
DCM 0.3 1.56 1.56 3.13 3.13 1.56 3.13
EtOH 1.0 1.56 0.39 3.13 3.13 6.25 6.25
Water 2.3 3.13 3.13 6.25 6.25 12.50 N12.50
Felicia erigeroides Leaves PE 1.5 1.56 3.13 3.13 3.13 6.25 6.25
DCM 4.5 1.56 1.56 1.56 1.56 6.25 6.25
EtOH 6.4 0.78 0.78 3.13 3.13 12.50 N12.50
Water 20.2 N12.50 12.50 N12.50 N12.50 1.56 3.13
Stems PE 0.3 0.78 0.78 3.13 3.13 6.25 6.25
DCM 0.6 0.78 1.56 1.56 1.56 6.25 6.25
EtOH 1.2 1.56 1.56 3.13 3.13 12.50 N12.50
Water 10.2 N12.50 12.50 12.50 12.50 12.50 N12.50
Hypoxis colchicifolia Leaves PE 2.4 0.78 0.78 3.13 3.13 0.78 0.78
DCM 3.0 0.78 0.78 1.56 1.56 1.56 6.25
EtOH 5.6 0.78 0.78 1.56 0.78 6.25 12.50
Water 7.1 N12.50 12.50 6.25 12.50 12.50 N12.50
Corms PE 0.3 6.25 6.25 6.25 6.25 6.25 N12.50
DCM 0.5 6.25 3.13 6.25 3.13 6.25 6.25
EtOH 10.6 3.13 3.13 6.25 3.13 6.25 6.25
Water 24.4 1.56 3.13 6.25 3.13 12.50 N12.50
Hypoxis hemerocallidea Leaves PE 0.8 1.56 1.56 3.13 3.13 6.25 12.50
DCM 1.1 0.78 0.78 1.56 3.13 1.56 6.25
EtOH 2.0 3.13 1.56 3.13 1.56 1.56 3.13
Hypoxis hemerocallidea Leaves Water 6.2 N12.50 3.13 3.13 3.13 N12.50 N12.50
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Table 3 (continued)
Plant species Plant part Extract a Extract yield
(%)
Antibacterial activity MIC b (mg/ml) Antifungal activity
Bacteria c Candida albicans
B.s. S.a. E.c. K.p. MIC b (mg/ml) MFCd (mg/ml)
Corms PE 0.2 3.13 3.13 6.25 3.13 6.25 12.50
DCM 0.4 3.13 1.56 6.25 3.13 6.25 12.50
EtOH 33.4 3.13 3.13 6.25 6.25 6.25 6.25
Water 35.0 N12.50 3.13 3.13 3.13 N12.50 N12.50
Ocimum basilicum Leaves PE 3.2 1.56 0.78 3.13 3.13 3.13 6.25
DCM 11.4 1.56 0.78 1.56 0.78 3.13 6.25
EtOH 7.8 3.13 1.56 0.78 0.78 3.13 6.25
Water 12.0 N12.50 3.13 N12.50 3.13 0.78 1.56
Senna petersiana Leaves PE 3.5 3.13 3.13 3.13 3.13 3.13 3.13
DCM 3.4 3.13 0.78 3.13 1.56 1.56 3.13
EtOH 8.4 0.39 0.39 0.78 0.39 1.56 1.56
Water 35.2 3.13 3.13 6.25 6.25 N12.50 N12.50
Neomycin (µg/ml) – – 1.56 1.56 0.39 0.78 – –
Amphotericin B (µg/ml) – – – – – – 0.15 9.80
– = not tested.
a Extract: PE = petroleum ether, DCM = dichloromethane, and EtOH = ethanol.
b MIC = minimum inhibitory concentration.
c Bacteria: B.s. = Bacillus subtilis, S.a. = Staphylococcus aureus, E.c. = Escherichia coli and K.p. = Klebsiella pneumoniae.
d MFC = minimum fungicidal concentration.
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The COX-1 and -2 inhibitions of the plant extracts are
presented in Table 4. Based on the scheme devised by Tunón et al.
(1995), four levels of inhibitory activity were defined. Percentage
activity of above 70% was regarded as ‘high’ inhibition, from 40
to 70% indicates ‘moderate’ inhibition, 20 to 40%was regarded as
‘low’ inhibition, below 20% was considered ‘insignificant’
inhibition at the extract concentration tested.Table 4
COX-1 and COX-2 inhibitions (%) of the plant extracts in the COX bioassaywhich was
water extracts, respectively. Values are presented as mean±standard error, where n=4
Plant species Plant
part
COX-1 inhibition (%)
PE DCM EtO
Acokanthera oppositifolia Leaves 98.2±4.6 99.8±1.8 97.
Twigs 0.0 31.5±2.7 0.0
Clerodendrum myricoides Leaves 51.5±2.7 76.7±2.1 0.0
Stems 68.9±0.8 84.4±2.2 10.
Cotyledon orbiculata var. dactylosis Leaves 70.1±4.0 98.0±1.5 98.
Stems 68.5±2.5 58.9±1.1 26.
Cotyledon orbiculata var. orbiculata Leaves 97.6±3.4 93.3±3.5 67.
Stems 0.0 62.6±5.0 97.
Cyathea dregei Leaves 98.0±0.5 73.8±2.9 99.
Roots 91.8±2.7 96.1±0.9 77.
Felicia erigeroides Leaves 93.6±1.8 99.4±1.1 87.
Stems 88.0±1.7 71.6±2.3 36.
Hypoxis colchicifolia Leaves 99.3±0.9 35.4±2.5 98.
Corms 93.6±1.8 96.4±1.2 0.0
Hypoxis hemerocallidea Leaves 60.7±1.3 78.4±2.9 0.0
Corms 97.1±3.0 98.4±1.3 0.0
Ocimum basilicum Leaves 62.0±5.9 76.7±2.2 94.
Senna petersiana Leaves 77.6±1.2 85.5±1.9 99.
Extracting solvents: PE= petroleum ether,DCM=dichloromethane andEtOH= ethanol
was 75.50±2.34 and COX-2 at final bioassay concentration of 200 µM was 69.10±2.The highest COX-1 inhibition was exhibited by the DCM
extract of A. oppositifolia leaves with 99.98% inhibition, DCM
extracts of F. erigeroides and H. hemerocallidea also had a
comparably high COX-1 inhibition. In COX-2 bioassay, the
most active extract was DCM extract of F. erigeroides stems
with 99% inhibition. High COX-2 inhibition was exhibited by
10 PE and DCM extracts while only six EtOH extracts and one
water extract displayed similar high COX-2 inhibition. In
general, non-polar solvent extracts showed higher COXtested at a final concentration of 250 µg/ml and 2 mg/ml for the organic solvent and
.
COX-2 inhibition (%)
H Water PE DCM EtOH Water
8±2.9 48.1±0.7 84.7±0.4 81.0±0.3 68.1±2.4 0.0
37.7±1.3 38.5±3.4 72.6±1.1 29.6±3.1 16.9±0.7
0.0 6.8±1.1 32. 8±2.4 42.5±0.8 0.0
4±2.7 16.3±0.9 74.5±0.7 70.9±0.6 54.2±1.4 0.0
0±1.3 27.3±1.6 58.8±2.8 72.6±4.0 73.1±3.8 10. 5±4.3
5±2.7 44.3±0.9 53.0±0.9 58.5±2.1 32.4±5.2 29.2±1.9
4 ±4.0 15.1±0.7 85.2 ±2.3 80. 8±0.7 66. 8±1.2 0.0
1±4.2 42.1±0.8 32.5±3.2 46.7±3.1 71.8±2.0 25.1±1.0
2±0.8 68.0±1.0 55.9±1.1 61.1±1.4 71.7±1.0 55.1±0.7
9±0. 2 84.2±1.2 70.1±4.3 74.3±1.7 48. 6±3.5 70.2±2.4
6±3.2 61.1±2.1 85.4±1.5 87.3±1.7 69.4±1.7 0.5±0.1
1±4.8 33.0±1.3 98.3±2.7 99.8±2.1 78.7±1.9 3.4±1.0
4±1.2 68.1±1.1 90.1±2.0 49.9±1.1 83.5±0.1 51.5±3.8
63.4±1.2 81.0±2.6 76.2±3.8 0.0 7. 9±0.6
59.6±1.2 37.4±2.1 55.2±1.3 19.9±0.3 2.7±0.9
83.0±1.3 74.2±2.5 69.1±1.3 0.0 25.7±1.2
1±2.4 83.6±0.6 94.4±0.8 67.1±2.3 85.7±2.4 30.2±1.0
3±1.2 92.5±0.4 65.2±2.3 77.7±0.1 47.8±3.8 56.8±1.6
. Inhibition (%) by indomethacin for COX-1 at final bioassay concentration of 5 µM
44.
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the extracting solvents (PE, DCM, EtOH and water) yielded 18
extracts out of which a total of 14 DCM and 11 PE extracts
compared to nine EtOH and four water extracts exhibited high
COX-1 inhibition. The inhibitory activity against COX-2
enzyme was lower than COX-1.
3.4. Phenolic composition
The total phenolics, gallotannin, condensed tannin and
flavonoid contents in the 50% MeOH extracts are depicted in
Fig. 1A, B, C and D, respectively. Besides the C. orbiculata var.
dactylopsis leaf and F. erigeroides stem extract that lacked
condensed tannin, the other extracts contained various pheno-
lics at varying concentrations. This disparity was especially
evident between the different plant parts, as well as among the
plant species investigated. The extract with the highest amountFig. 1. Phenolic content of South African medicinal plants used as anthelmintics.
(A) Total phenolic content; (B) gallotannin content; (C) condensed tannin content;
(D) flavonoid content. A.o. L— Acokanthera oppositifolia (leaves), A.o. T— A.
oppositifolia (twigs), C.m. L— Clerodendrum myricoides (leaves), C.m. S— C.
myricoides (stems), C.o. L— Cotyledon orbiculata var. dactylopsis (leaves), C.o.
S — C. orbiculata var. dactylopsis (stems), C.o.* L — C. orbiculata var.
orbiculata (leaves), C.o.* S — C. orbiculata var. orbiculata (stems), C.d. L —
Cyathea dregei (leaves), C.d. R— C. dregei (roots), F.e. L— Felicia erigeroides
(leaves), F.e. S— F. erigeroides (stems),H.c. L—Hypoxis colchicifolia (leaves),
H.c. C—H. colchicifolia (corms),H.h. L—H. hemerocallidea (leaves),H.h. C—
H. hemerocallidea (corms),O.b. L—Ocimumbasilicum (leaves), S.p. L— Senna
petersiana (leaves).(56.70 mg GAE/g dry matter) of total phenolics was O.
basilium leaves while the lowest quantity (1.70 mg GAE/g
dry matter) was found in C. orbiculata var. dactylopsis (leaves).
The gallotannin concentration in the 50% MeOH extracts
ranged from 45.36 µg GAE/g dry matter determined in O.
basilicum leaves to 1.36 µg GAE/g dry matter in C. orbiculata
var. dactylopsis leaves. The condensed tannin content in the
50% MeOH extracts of plant material ranged from 0.009%
LCE/g dry matter in C. orbiculata var. orbiculata leaves to
0.48% LCE/g dry matter in C. myricoides leaves. The corm
extract of H. hemerocallidea had the highest flavonoid
concentration of 0.462 µg CTE/g dry matter while the lowest
flavonoid concentration of 0.008 µg CTE/g dry matter was
observed in the leaf extract of C. orbiculata var. orbiculata.
4. Discussion and conclusions
Apart fromH. hemerocallidea, all the plant species had at least
one extract from the screened parts showing high anthelmintic
activity. The potential anthelmintic activity shown by these plant
extracts confirms the importance of using an ethnopharmacolo-
gical approach in screening plants as a source of novel
pharmaceuticals. This approach provides a valuable short-cut
by taking advantage of information available from traditional
healers and ethnopharmacological records (Elgorashi and Van
Staden, 2004). The extracts of C. dregei leaves exhibited better
anthelmintic activity than the root extracts, although traditional
healers are known to use the dried roots as an anthelmintic
(Hutchings et al., 1996). The destructive harvesting of the roots
for medicinal uses is probably responsible for this plant being
listed as a threatened species in southern Africa (Talukdar, 2002).
This study has shown that the leaves could be substituted for the
roots as anthelmintic medication by traditional healers. However,
further investigation will be necessary to support this plant part
substitution.
Although it is ideal to test plant extracts against specific target
microorganisms, representative microbes were used in this
preliminary antimicrobial screening to avoid handling numerous
pathogenic microorganisms. Activity against these selected
microorganisms will give an indication of possible similar action
against more pathogenic strains (Taylor et al., 2001). The most
susceptible bacteriumwas S. aureus and themost resistantE. coli.
The presence of unique lipopolysaccharides on the outer
membrane of Gram-negative bacteria makes them impermeable
tomost antibacterial compounds (Clements et al., 2002). This can
explain the low number of active plant extracts against E. coli and
K. pneumoniae. The observed trend is in agreement with previous
research findings by various workers (Lin et al., 1999;
Tshikalange et al., 2005). C. albicans was not sensitive to the
majority of extracts screened. Pathogenic fungi are more resistant
to most therapies used against other infections such as bacteria
(Sleigh and Timburg, 1998). Antifungal activity screening of
plant extracts by other workers also showed that pathogenic fungi
are resistant to most plant extracts (Buwa and Van Staden, 2006;
Fawole et al., 2009).
Although a high number of extracts inhibited both the COX-1
and -2 enzymes, many extracts showed better COX-1 inhibition
565A.O. Aremu et al. / South African Journal of Botany 76 (2010) 558–566than COX-2 which could be attributed to the COX-1 active site
being smaller than that of COX-2 (Botting, 2006). The high to
moderate inhibitory activity exhibited by most leaf extracts
against COX-2 inhibition is important for conservation of
medicinal plant species. For example, extracts from the leaves
of plant species such as H. colchicifolia and C. dregei exhibited
better COX-2 inhibition activity than the underground parts.
Leaves can be harvested sustainablywhile utilizing these plants as
medicine without the inherent survival threat associated with
destructive harvesting of underground parts such as corms and
roots. The observed high COX-2 inhibitory activity of the leaf
extracts was in line with the suggestion for the need to investigate
non-destructive medicinal plant parts for possible noteworthy
similar pharmacological activity as present in the underground
parts (Zschocke et al., 2000).
In the three bioassays used in this study, water extracts
generally exhibited poor pharmacological activities. Although
traditional healers often use water or alcohol for extracting
medicinal plants, studies have shown that the use of water for
plant material extraction naturally limits the type and amount of
compounds extracted (Eloff, 1998b). This probably indicates
that dosage is important with regard to which solvent is being
used. A number of extracts exhibited poor pharmacological
activity, especially antimicrobial activity. The absence of
significant activity could be due to factors such as dilution of
active principle(s) and antagonistic effects by other compounds
against the active principle(s) and not necessarily the inactivity
of the plant extracts (Taylor et al., 2001). Generally, extracts
from plants such asC. dregei, F. erigeroides andH. colchicifolia
showed noteworthy pharmacological activity in the three
bioassays, supporting the recommendation by Houghton et al.
(2005) for the need to investigate plant extracts in multiple in
vitro tests associated with the disease state. In this study, many of
the extracts inhibited both COX-1 and -2. This denotes the
potential of these extracts to reduce inflammation. They are
possibly used in TM to reduce pain which is associated with
helminth infections. Besides, TM lacks scientific investigations
to determine the cause of diseases and common symptoms that
are observed provide a clue on plant material used and other
treatment regimes (Hewson, 1998).
The phenolics as well as gallotannin, condensed tannin and
flavonoid content, varied in the plant extracts investigated.
Plants with high phenolic content have been popularly used as
anthelmintics, antimicrobials (Polya, 2003) and anti-inflamma-
tories (Erdèlyi et al., 2005). The results obtained from the
investigation of phenolic content provide preliminary informa-
tion on some important groups of phenolics that are present in
the plants investigated. This also suggests the types of bioactive
compounds that may be responsible for the biological activities
exhibited by the plant extracts.
Although remarkable biological activity identified from
these in vitro tests does not necessarily confirm that the active
plant extracts are effective medicines, nor suitable candidates
for drug development, it does provide basic knowledge of the
efficacy of the plant material. Preliminary in vitro screening
techniques are a crucial and important step in the long and
expensive process of drug discovery and development fromplants. Further investigation of these extracts against more
pathogenic strains of test organisms as well as the use of in vivo
test systems will also be necessary to further ascertain their
pharmacological effectiveness. Studies on the toxicology of
active extracts as well as isolation of active compounds from the
extracts of plants such as C. dregei, and F. erigeroides are on-
going in our laboratories.
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